Burning Rock Biotech Limited
Burning Rock Biotech Limited (BNR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bnr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Burning Rock Biotech Limited (BNR) measures how much investors pay for each dollar of the company's trailing earnings. BNR's current PE ratio of N/A is calculated by dividing its stock price of $9.07 by its TTM earnings per share of -$52.83.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Burning Rock Biotech LimitedYou BNR | $10M | N/A | — | -$52.83 |
 Advanced Biomed Inc. Common Stock ADVB | $4M | N/A | — | -$0.09 |
 Aethlon Medical, Inc. AEMD | $2M | N/A | — | -$85.77 |
 Allurion Technologies Inc. ALUR | $6M | N/A | — | -$0.38 |
 American Shared Hospital Services AMS | $9M | N/A | — | -$0.23 |
 Aytu BioPharma, Inc. AYTU | $19M | N/A | — | -$2.16 |
 Co-Diagnostics, Inc. CODX | $6M | N/A | — | -$35.25 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-51.32 | — | |
2024-12-31 FY2024 | — | $-33.67 | — | |
2023-12-31 FY2023 | — | $-63.84 | — | |
2022-12-31 FY2022 | — | $-93.47 | — | |
2021-12-31 FY2021 | — | $-76.45 | — | |
2020-12-31 FY2020 | — | $-68.76 | — | |
2019-12-31 FY2019 | — | $-141.61 | — | |
2018-12-31 FY2018 | — | $-103.82 | — | |
2017-12-31 FY2017 | — | $-102.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Burning Rock Biotech Limited (BNR) measures how much investors pay for each dollar of the company's trailing earnings. BNR's current PE ratio of N/A is calculated by dividing its stock price of $9.07 by its TTM earnings per share of -$52.83.
Frequently asked questions
BNR pe ratio · 6 questionsBNR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $9.07 and TTM EPS of -$52.83. Data sourced from Financial Modeling Prep via BNR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Burning Rock Biotech Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09